Park Ha Biological Technology Co., Ltd. (PHH)
NASDAQ: PHH · Real-Time Price · USD
0.4119
-0.0121 (-2.85%)
At close: Oct 14, 2025, 4:00 PM EDT
0.4239
+0.0120 (2.91%)
After-hours: Oct 14, 2025, 7:48 PM EDT
PHH Revenue
Park Ha Biological Technology had revenue of $1.24M in the half year ending April 30, 2025, a decrease of -9.65%. This brings the company's revenue in the last twelve months to $2.77M, up 42.65% year-over-year. In the fiscal year ending October 31, 2024, Park Ha Biological Technology had annual revenue of $2.38M, down -3.14%.
Revenue (ttm)
$2.77M
Revenue Growth
+42.65%
P/S Ratio
3.86
Revenue / Employee
$162,831
Employees
17
Market Cap
13.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 2.38M | -77.25K | -3.14% |
| Oct 31, 2023 | 2.46M | 539.71K | 28.12% |
| Oct 31, 2022 | 1.92M | 988.35K | 106.16% |
| Oct 31, 2021 | 931.04K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPHH News
- 10 months ago - Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering - GlobeNewsWire
- 10 months ago - Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering - GlobeNewsWire
- 1 year ago - Park Ha Biological Aims For U.S. IPO At Sky-High Valuation - Seeking Alpha
- 1 year ago - U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market - Seeking Alpha
- 1 year ago - Chinese skincare product company Park Ha Biological Technology files and sets terms for a $7 million US IPO - Renaissance Capital
- 1 year ago - Park Ha Biological Technology IPO Registration Document (F-1) - SEC